Qualigen Therapeutics Inc (QLGN)
NASDAQ:QLGN
Holding QLGN?
Track your performance easily

Qualigen Therapeutics (QLGN) Financial Statements

624 Followers

Qualigen Therapeutics Financial Overview

Qualigen Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.613; its P/E ratio is -0.11; Qualigen Therapeutics is scheduled to report earnings on August 13, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Jun 23Mar 23
Income Statement-
Total Revenue--$ -3.23M$ 1.63M$ 1.61M
Gross Profit--$ -3.23M$ 1.63M$ 1.61M
EBIT$ -1.73M$ -1.89M$ -1.92M$ -3.17M$ -4.82M
EBITDA$ -1.73M$ -1.89M$ -1.92M$ -3.05M$ -4.70M
Net Income Common Stockholders$ -1.58M$ -2.09M$ -2.45M$ -3.46M$ 5.57M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 118.69K$ 100.00K$ 400.00K$ 1.30M$ 4.41M
Total Assets$ 534.41K$ 1.01M$ 2.03M$ 13.15M$ 15.91M
Total Debt$ 0.00$ 1.02M$ 1.30M$ 3.20M$ 3.00M
Net Debt$ -118.69K$ 922.87K$ 899.22K$ 1.90M$ -1.40M
Total Liabilities$ 3.10M$ 4.52M$ 4.14M$ 9.84M$ 9.71M
Stockholders Equity$ -4.28M$ -3.49M$ -2.10M$ 2.03M$ 4.87M
Cash Flow-
Free Cash Flow$ -1.47M$ -783.59K$ -5.70M$ -3.05M$ -2.80M
Operating Cash Flow$ -1.47M$ -783.59K$ -5.70M$ -3.00M$ -2.60M
Investing Cash Flow$ 350.00K-$ 235.40K$ -48.41K$ -198.01K
Financing Cash Flow$ 1.15M$ 475.00K$ -110.00K--
Currency in USD

Qualigen Therapeutics Earnings and Revenue History

Qualigen Therapeutics Debt to Assets

Qualigen Therapeutics Cash Flow

Qualigen Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis